DTEA Fundamental Analysis - DAVIDSTEA INC

Fundamental Rating

Taking everything into account, DTEA scores 2 out of 10 in our fundamental rating. DTEA was compared to 16 industry peers in the Specialty Retail industry. While DTEA seems to be doing ok healthwise, there are quite some concerns on its profitability. DTEA does not seem to be growing, but still is valued expensively.

Quickly go to:

1. Profitability

1.1 Basic Checks

In the past year DTEA has reported negative net income.

In the past year DTEA had a positive cash flow from operations.

DTEA had negative earnings in 4 of the past 5 years.

In multiple years DTEA reported negative operating cash flow during the last 5 years.

1.2 Ratios

The Return On Assets of DTEA (-1.95%) is worse than 75.00% of its industry peers.

The Return On Equity of DTEA (-4.78%) is worse than 75.00% of its industry peers.

		Industry Rank	Sector Rank
ROA	-1.95%
ROE	-4.78%
ROIC	N/A

ROA(3y)-20.71%

ROA(5y)-6.31%

ROE(3y)-41.53%

ROE(5y)N/A

ROIC(3y)N/A

ROIC(5y)N/A

1.3 Margins

With a decent Gross Margin value of 49.45%, DTEA is doing good in the industry, outperforming 75.00% of the companies in the same industry.

DTEA's Gross Margin has declined in the last couple of years.

The Profit Margin and Operating Margin are not available for DTEA so they could not be analyzed.

		Industry Rank	Sector Rank
OM	N/A
PM (TTM)	N/A
GM	49.45%

OM growth 3YN/A

OM growth 5YN/A

PM growth 3YN/A

PM growth 5YN/A

GM growth 3Y5.52%

GM growth 5Y-2.86%

More info and screens

ROA

ROE

ROIC

Operating and Profit Margin

Show most profitable peers

2. Health

2.1 Basic Checks

DTEA does not have a ROIC to compare to the WACC, probably because it is not profitable.

DTEA has more shares outstanding than it did 1 year ago.

DTEA has more shares outstanding than it did 5 years ago.

DTEA has a worse debt/assets ratio than last year.

2.2 Solvency

DTEA has an Altman-Z score of -1.22. This is a bad value and indicates that DTEA is not financially healthy and even has some risk of bankruptcy.

DTEA has a Altman-Z score of -1.22. This is amonst the worse of the industry: DTEA underperforms 81.25% of its industry peers.

DTEA has a debt to FCF ratio of 2.25. This is a good value and a sign of high solvency as DTEA would need 2.25 years to pay back of all of its debts.

DTEA's Debt to FCF ratio of 2.25 is fine compared to the rest of the industry. DTEA outperforms 75.00% of its industry peers.

DTEA has a Debt/Equity ratio of 0.49. This is a healthy value indicating a solid balance between debt and equity.

DTEA has a better Debt to Equity ratio (0.49) than 62.50% of its industry peers.

		Industry Rank	Sector Rank
Debt/Equity	0.49
Debt/FCF	2.25
Altman-Z	-1.22

ROIC/WACCN/A

WACC8.31%

2.3 Liquidity

DTEA has a Current Ratio of 1.70. This is a normal value and indicates that DTEA is financially healthy and should not expect problems in meeting its short term obligations.

Looking at the Current ratio, with a value of 1.70, DTEA belongs to the top of the industry, outperforming 87.50% of the companies in the same industry.

A Quick Ratio of 0.72 indicates that DTEA may have some problems paying its short term obligations.

The Quick ratio of DTEA (0.72) is comparable to the rest of the industry.

		Industry Rank	Sector Rank
Current Ratio	1.7
Quick Ratio	0.72

More info and screens

WACC

Debt/Equity

How to determine the health of a company

Altman-Z score

Show peers with great health

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 93.21% over the past year.

DTEA shows a small growth in Revenue. In the last year, the Revenue has grown by 1.50%.

DTEA shows a very negative growth in Revenue. Measured over the last years, the Revenue has been decreasing by -20.65% yearly.

EPS 1Y (TTM)93.21%

EPS 3YN/A

EPS 5YN/A

EPS Q2Q%-4.34%

Revenue 1Y (TTM)1.5%

Revenue growth 3Y-15.95%

Revenue growth 5Y-20.65%

Sales Q2Q%-0.18%

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.

No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.

EPS Next YN/A

EPS Next 2YN/A

EPS Next 3YN/A

EPS Next 5YN/A

Revenue Next YearN/A

Revenue Next 2YN/A

Revenue Next 3YN/A

Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.

No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.

More info and screens

Find the best growth stocks

Show best growing peers

4. Valuation

4.1 Price/Earnings Ratio

DTEA reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.

		Industry Rank	Sector Rank
PE	N/A
Fwd PE	N/A

4.2 Price Multiples

The rest of the industry has a similar Enterprise Value to EBITDA ratio as DTEA.

DTEA's Price/Free Cash Flow ratio is rather cheap when compared to the industry. DTEA is cheaper than 81.25% of the companies in the same industry.

		Industry Rank	Sector Rank
P/FCF	4.57
EV/EBITDA	12.14

4.3 Compensation for Growth

PEG (NY)N/A

PEG (5Y)N/A

EPS Next 2YN/A

EPS Next 3YN/A

More info and screens

Show best valued peers

5. Dividend

5.1 Amount

No dividends for DTEA!.

		Industry Rank	Sector Rank
Dividend Yield	N/A

More info and screens

Find the best dividend stocks

Show peers with best dividend

DAVIDSTEA INC

TSX-V:DTEA (11/26/2025, 7:00:00 PM)

0.92

+0.01 (+1.1%)

Chartmill FA Rating

GICS SectorConsumer Discretionary

GICS IndustryGroupConsumer Discretionary Distribution & Retail

GICS IndustrySpecialty Retail

Earnings (Last)09-16 2025-09-16/bmo

Earnings (Next)12-16 2025-12-16

Inst Owners11.22%

Inst Owner ChangeN/A

Ins Owners3.24%

Ins Owner ChangeN/A

Market Cap24.79M

Revenue(TTM)61.94M

Net Income(TTM)-804.00K

Analysts45.71

Price TargetN/A

Short Float %N/A

Short RatioN/A

Dividend

		Industry Rank	Sector Rank
Dividend Yield	N/A

Yearly DividendN/A

Dividend Growth(5Y)N/A

DPN/A

Div Incr Years0

Div Non Decr Years0

Ex-DateN/A

Surprises & Revisions

EPS beat(2)N/A

Avg EPS beat(2)N/A

Min EPS beat(2)N/A

Max EPS beat(2)N/A

EPS beat(4)N/A

Avg EPS beat(4)N/A

Min EPS beat(4)N/A

Max EPS beat(4)N/A

EPS beat(8)N/A

Avg EPS beat(8)N/A

EPS beat(12)N/A

Avg EPS beat(12)N/A

EPS beat(16)N/A

Avg EPS beat(16)N/A

Revenue beat(2)N/A

Avg Revenue beat(2)N/A

Min Revenue beat(2)N/A

Max Revenue beat(2)N/A

Revenue beat(4)N/A

Avg Revenue beat(4)N/A

Min Revenue beat(4)N/A

Max Revenue beat(4)N/A

Revenue beat(8)N/A

Avg Revenue beat(8)N/A

Revenue beat(12)N/A

Avg Revenue beat(12)N/A

Revenue beat(16)N/A

Avg Revenue beat(16)N/A

PT rev (1m)N/A

PT rev (3m)N/A

EPS NQ rev (1m)N/A

EPS NQ rev (3m)N/A

EPS NY rev (1m)N/A

EPS NY rev (3m)N/A

Revenue NQ rev (1m)N/A

Revenue NQ rev (3m)N/A

Revenue NY rev (1m)N/A

Revenue NY rev (3m)N/A

Valuation

		Industry Rank	Sector Rank
PE	N/A
Fwd PE	N/A
P/S	0.4
P/FCF	4.57
P/OCF	3.91
P/B	1.47
P/tB	1.47
EV/EBITDA	12.14

EPS(TTM)-0.03

EYN/A

EPS(NY)N/A

Fwd EYN/A

FCF(TTM)0.2

FCFY21.86%

OCF(TTM)0.24

OCFY25.6%

SpS2.3

BVpS0.62

TBVpS0.62

PEG (NY)N/A

PEG (5Y)N/A

Graham NumberN/A

Profitability

		Industry Rank	Sector Rank
ROA	-1.95%
ROE	-4.78%
ROCE	N/A
ROIC	N/A
ROICexc	N/A
ROICexgc	N/A
OM	N/A
PM (TTM)	N/A
GM	49.45%
FCFM	8.75%

ROA(3y)-20.71%

ROA(5y)-6.31%

ROE(3y)-41.53%

ROE(5y)N/A

ROIC(3y)N/A

ROIC(5y)N/A

ROICexc(3y)N/A

ROICexc(5y)N/A

ROICexgc(3y)N/A

ROICexgc(5y)N/A

ROCE(3y)N/A

ROCE(5y)N/A

ROICexgc growth 3YN/A

ROICexgc growth 5YN/A

ROICexc growth 3YN/A

ROICexc growth 5YN/A

OM growth 3YN/A

OM growth 5YN/A

PM growth 3YN/A

PM growth 5YN/A

GM growth 3Y5.52%

GM growth 5Y-2.86%

F-Score4

Asset Turnover1.5

Health

		Industry Rank	Sector Rank
Debt/Equity	0.49
Debt/FCF	2.25
Debt/EBITDA	3.39
Cap/Depr	21.12%
Cap/Sales	1.5%
Interest Coverage	N/A
Cash Conversion	262.53%
Profit Quality	N/A
Current Ratio	1.7
Quick Ratio	0.72
Altman-Z	-1.22

F-Score4

WACC8.31%

ROIC/WACCN/A

Cap/Depr(3y)36.98%

Cap/Depr(5y)24.87%

Cap/Sales(3y)2.08%

Cap/Sales(5y)1.41%

Profit Quality(3y)N/A

Profit Quality(5y)N/A

High Growth Momentum

Growth

EPS 1Y (TTM)93.21%

EPS 3YN/A

EPS 5YN/A

EPS Q2Q%-4.34%

EPS Next YN/A

EPS Next 2YN/A

EPS Next 3YN/A

EPS Next 5YN/A

Revenue 1Y (TTM)1.5%

Revenue growth 3Y-15.95%

Revenue growth 5Y-20.65%

Sales Q2Q%-0.18%

Revenue Next YearN/A

Revenue Next 2YN/A

Revenue Next 3YN/A

Revenue Next 5YN/A

EBIT growth 1Y73.77%

EBIT growth 3YN/A

EBIT growth 5YN/A

EBIT Next YearN/A

EBIT Next 3YN/A

EBIT Next 5YN/A

FCF growth 1Y207.55%

FCF growth 3YN/A

FCF growth 5Y-24.41%

OCF growth 1Y291.78%

OCF growth 3YN/A

OCF growth 5Y-23.2%

DAVIDSTEA INC / DTEA.CA FAQ

What is the fundamental rating for DTEA stock?

ChartMill assigns a fundamental rating of 2 / 10 to DTEA.CA.

What is the valuation status for DTEA stock?

ChartMill assigns a valuation rating of 2 / 10 to DAVIDSTEA INC (DTEA.CA). This can be considered as Overvalued.

What is the profitability of DTEA stock?

DAVIDSTEA INC (DTEA.CA) has a profitability rating of 1 / 10.

Can you provide the financial health for DTEA stock?

The financial health rating of DAVIDSTEA INC (DTEA.CA) is 4 / 10.

DAVIDSTEA INC (DTEA.CA) Stock Fundamental Analysis

1. Profitability

1.1 Basic Checks

1.2 Ratios

1.3 Margins

More info and screens

2. Health

2.1 Basic Checks

2.2 Solvency

2.3 Liquidity

More info and screens

3. Growth

3.1 Past

3.2 Future

3.3 Evolution

More info and screens

4. Valuation

4.1 Price/Earnings Ratio

4.2 Price Multiples

4.3 Compensation for Growth

More info and screens

5. Dividend

5.1 Amount

More info and screens

DAVIDSTEA INC / DTEA.CA FAQ

What is the fundamental rating for DTEA stock?

What is the valuation status for DTEA stock?

What is the profitability of DTEA stock?

Can you provide the financial health for DTEA stock?